Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 739

Results For "ED"

7602 News Found

Panacea Biotec gets license to produce Sputnik V vaccine at Baddi
News | July 05, 2021

Panacea Biotec gets license to produce Sputnik V vaccine at Baddi

The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli in India


Ajooni Biotech to establish first Oxygen Park in Punjab
News | July 05, 2021

Ajooni Biotech to establish first Oxygen Park in Punjab

Oxygen Park is a concept where a two-layer layout is being used to plant oxygen releasing trees which releases oxygen for 24 hours


Zydus Cadila receives USFDA approval for Emtricitabine and Tenofovir Disoproxil
News | July 04, 2021

Zydus Cadila receives USFDA approval for Emtricitabine and Tenofovir Disoproxil

The drug is used with other HIV medications to help control HIV infection and it helps to decrease the amount of HIV in one’s body so that the immune system can work better


Phyto Chem India posts loss of Rs. 18.57 lakhs in Q4
News | July 04, 2021

Phyto Chem India posts loss of Rs. 18.57 lakhs in Q4

The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021


Laurus receives license to manufacture and market 2DG
News | July 04, 2021

Laurus receives license to manufacture and market 2DG

2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country


Solara announces restoration of CEP for ranitidine hydrochloride
News | July 03, 2021

Solara announces restoration of CEP for ranitidine hydrochloride

Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site


Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr
News | July 02, 2021

Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr

The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021


Sandu Pharmaceuticals Q4FY21 PAT at Rs. 46.14 lakhs
News | July 02, 2021

Sandu Pharmaceuticals Q4FY21 PAT at Rs. 46.14 lakhs

The company has posted net profit of Rs.1.09 crores for the 12 months period ended March 31, 2021


Lupin receives tentative U.S. FDA approval for Dolutegravir, Lamivudine and TLD tablets
News | July 01, 2021

Lupin receives tentative U.S. FDA approval for Dolutegravir, Lamivudine and TLD tablets

TLD is recommended by WHO, USAID, and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and pediatric patients weighing at least 35 kg


Triastek closes US $50 Mn Series B Financing
News | July 01, 2021

Triastek closes US $50 Mn Series B Financing

In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline